Healthcare costs attributable to the treatment of patients with spinal metastases: a cohort study with up to 8 years follow-up

Table 1 Baseline characteristics of 629 spinal metastases patients

	Copenhagen database (n = 419)		Aarhus database (n = 210)
	n	%	n	%
Male	245	58	134	64
Age (years)
15-54	62	15	42	20
55-64	115	27	68	32
65-74	137	33	71	34
75-84	81	19	26	12
≥85	24	6	3	1
Primary cancer
Prostate	97	23	67	32
Lung	99	24	22	10
Breast	75	18	41	20
Other	148	35	80	38
Predicted survival time* (months)
0-6	198	47	107	51
6-12	122	29	76	36
>12	99	24	27	13
Treatment
T1	419	100
T2			51	24
T3			79	38
T4			80	38

*Based on the Tokuhashi scoring system at baseline.
T1 conservative, T2 decompression, T3 decompression + instrumentation, T4 decompression + instrumentation + reconstruction.

ISSN: 1471-2407